Restart Life Sciences Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NMLSF research report →
Price Chart
About the company
Restart Life Sciences Corp. , through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing natural remedies specifically tailored for individuals on the autism spectrum; health-related foods that promote both mind and body wellness for healthy living, as well as psilocybin clinical trial for fragile X syndrome.
- CEO
- Steve Loutskou
- IPO
- 2011
- HQ
- Vancouver, BC, CA
Get TickerSpark's AI analysis on NMLSF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.29M
- P/E
- -1.87
- PEG
- 0.07
- P/S
- 19.02
- P/B
- 2.56
- EV/EBITDA
- -1.83
- Div Yield
- 0.00%
- Gross Margin
- -80.81%
- Op Margin
- -723.29%
- Net Margin
- -667.34%
- ROE
- -130.86%
- ROIC
- -51.29%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-1,347+16.1%
- Op Income
- $-1,345,316
- Net Income
- $-1,390,538-718.7%
- EPS
- $-0.00-102.7%
- OCF Growth
- -899.3%
- FCF Growth
- -899.3%
- 52W High
- $0.12
- 52W Low
- $0.01
- 50D MA
- $0.06
- 200D MA
- $0.07
- Beta
- -0.80
- RSI (14)
- 50
- Avg Volume
- 1.50K
No earnings-call transcripts are available for NMLSF yet.
- Free Float
- 77.3%
- Shares Outstanding
- 36.55M
- Float Shares
- 28.26M
of shares held by institutions
1 13F filers
Our NMLSF coverage
Recent articles, reports, and earnings notes.
No research on NMLSF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NMLSF report →Restart Life Sciences Announces Production Launch of New Holy Crap Protein Line
newsfilecorp.com · Aug 11
Restart Life Sciences Announces Strategic Focus on Targeted M&A Expansion in Health and CPG Sectors
newsfilecorp.com · Jul 29
Restart Life Sciences Details U.S. E-Commerce Launch, AI Platform, and Three-Phase Expansion Strategy for Holy Crap Foods
newsfilecorp.com · Jul 21
Restart Life Sciences Leverages University of Manitoba RCFTR Collaboration for Pre-Production Transition of New Protein Frameworks
newsfilecorp.com · Jul 14
Restart Life Sciences Details Next-Generation Product Pipeline and Segment Expansion for Holy Crap
newsfilecorp.com · Jul 8
Restart Life Sciences Reports Record-Breaking June Revenue for Holy Crap Foods as Amazon Canada Sales Surge YoY
newsfilecorp.com · Jul 2
Restart Life Advances AI-Driven E-Commerce Strategy to Scale Online Sales Growth for Holy Crap Foods
newsfilecorp.com · Jun 18
Restart Life Subsidiary Holy Crap Foods Marks New International Expansion Milestone with Bahamas On-Demand App Launch
newsfilecorp.com · Jun 10
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.